Q32 Bio Inc. (QTTB) Other Accumulated Expenses (2017 - 2023)

Q32 Bio has reported Other Accumulated Expenses for 7 years, with the latest figure at $325000.0 in Q4 2023.

• On a quarterly basis, Other Accumulated Expenses fell 96.56% year-over-year to $325000.0 in Q4 2023; TTM through Dec 2023 was $325000.0, a 96.56% decrease from a year earlier, with the FY2023 full-year figure at $325000.0, down 96.56% from the prior year.
• Other Accumulated Expenses was $325000.0 for Q4 2023 at Q32 Bio, down from $8.2 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $12.6 million in Q2 2023, with the low at $325000.0 in Q4 2023.
• Average Other Accumulated Expenses over 5 years is $4.5 million, with a median of $2.6 million recorded in 2021.
• The sharpest annual moves came in 2019 and 2023: Other Accumulated Expenses soared 831.33% in 2019, then plunged 96.56% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $2.3 million in 2019, then advanced by 5.98% to $2.4 million in 2020, then dropped by 8.36% to $2.2 million in 2021, then jumped by 330.78% to $9.4 million in 2022, then slumped by 96.56% to $325000.0 in 2023.
• The last three Other Accumulated Expenses figures came in at $325000.0 (Q4 2023), $8.2 million (Q3 2023), and $12.6 million (Q2 2023), per Business Quant data.